0000904454-14-000643.txt : 20140915
0000904454-14-000643.hdr.sgml : 20140915
20140915213740
ACCESSION NUMBER: 0000904454-14-000643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140911
FILED AS OF DATE: 20140915
DATE AS OF CHANGE: 20140915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001457612
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-876-8191
MAIL ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giannasca Paul
CENTRAL INDEX KEY: 0001591874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 141104399
MAIL ADDRESS:
STREET 1: CAMBRIDGE DISCOVERY PARK
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-09-11
0001457612
GENOCEA BIOSCIENCES, INC.
GNCA
0001591874
Giannasca Paul
C/O GENOCEA BIOSCIENCES, INC.
100 ACORN PARK DRIVE, 5TH FLOOR
CAMBRIDGE
MA
02140
0
1
0
0
VP of Development
Common Stock
2014-09-11
4
M
0
4071
2.02
A
4071
D
Common Stock
2014-09-11
4
S
0
4071
11.84
D
0
D
Stock Option (Right to Buy)
2.02
2014-09-11
4
M
0
4071
0
D
2021-02-16
Common Stock
4071
4259
D
The option vests in equal monthly installments over four years beginning on the date of grant (02/17/2011).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/Robert E. Farrell, Jr., Attorney-in-fact
2014-09-15